• Breaking Down the New Food Pyramid (Great or Confusing)
    Jan 12 2026

    Takeaways:

    Dietary guidelines have evolved since the 1980s.

    The food pyramid was introduced in 1992 and has influenced public perception.

    New dietary guidelines emphasize healthy fats but retain some old recommendations.

    There are contradictions in the new guidelines regarding saturated fat and protein intake.

    The definition of processed foods remains vague and controversial.

    The guidelines are intended for healthcare professionals, not consumers.

    Public policy needs to align with dietary guidelines for effective implementation.

    The emphasis on real food is not a new concept in dietary guidelines.

    There is skepticism about whether the new guidelines will lead to meaningful changes in public health.

    The conversation around dietary guidelines is often politically charged.

    Follow Kevin: Tap Here


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    30 mins
  • Cortisol Myths vs Reality: What Your Adrenals Actually Do
    Jan 7 2026

    Takeaways:

    Cortisol is essential for various bodily functions, especially during stress.

    Adrenal glands have a circadian rhythm that affects cortisol production.

    Cushing's syndrome can result from excess cortisol and has specific symptoms.

    Diagnosis of adrenal disorders requires careful testing and consideration of symptoms.

    Mild autonomous cortisol secretion can complicate diabetes management.

    The Catalyst trial explored the effects of cortisol antagonism on diabetes.

    Future research may focus on selective glucocorticoid receptor modulators.

    Woolly mammoth studies provide insights into historical testosterone levels.

    Understanding adrenal health is crucial for effective patient care.

    Endocrinologists must navigate the complexities of hormone testing and treatment.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    1 hr and 3 mins
  • GLP-1 Side Effects Deep Dive: Slimmer's Paralysis, Bladder Spasms, & Reactive Hypoglycemia.
    Dec 5 2025

    Takeaways:

    Slimmer's Paralysis is a recognized condition.

    Ethical boundaries are crucial in patient relationships.

    Medical professionals must maintain professionalism at all times.

    Humor can sometimes arise in serious discussions.

    Patient stories should always be handled with care.

    The importance of clear communication in medical settings.

    Understanding patient experiences is vital for effective care.

    Ethics in medicine is a complex and nuanced topic.

    Medical discussions can lead to unexpected topics.

    Maintaining a professional demeanor is essential.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    32 mins
  • GLP-1s and Breast Milk: What the New Research Actually Found
    Nov 19 2025

    Takeaways:

    Drug transfer during lactation is complex and challenging.

    Semaglutide was not detected in women taking any dose.

    Low amounts of tears epitide were found in milk.

    Tissue damage can affect drug absorption.

    Mastitis and engorgement complicate the lactation process.

    Injections are necessary for effective drug delivery.

    The analogy of an elephant illustrates the difficulty of drug transfer.

    Detection of drugs in milk is a critical concern for breastfeeding mothers.

    Understanding turnover is essential in lactation studies.

    The implications of drug transfer on women's health are significant.

    Infant Risk Center Link


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    34 mins
  • How to Build Healthy Routines That Actually Stick
    Nov 12 2025

    Takeaways:

    Behavior change is a complex process that requires understanding motivation and discipline.

    Motivation is not just a feeling; it's a psychological skill that can be developed.

    Many common phrases about behavior change are misleading and oversimplified.

    Exercise should be viewed as a choice rather than a habit that becomes automatic.

    Self-efficacy is crucial for successful behavior change and can be built through mastery experiences.

    Future self thinking can help individuals align their actions with their long-term goals.

    It's important to lower barriers to entry for new behaviors to increase adherence.

    Modeling healthy behaviors is essential for influencing children and adolescents.

    The psychological definition of a habit differs from the colloquial use of the term.

    Resources and support systems are vital for individuals looking to change their behaviors.

    Follow Dr. Nordin Here

    https://bodybrainalliance.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    35 mins
  • The Truth About Testosterone Therapy in Women (with Dr. Susan Davis)
    Nov 3 2025
    • Testosterone therapy can improve libido in postmenopausal women.
    • Sexual dysfunction in women is complex and multifactorial.
    • Low sexual desire is only considered a disorder if it causes distress.
    • Psychosocial factors play a significant role in sexual health.
    • Testosterone levels do not change significantly at menopause.
    • The placebo effect can significantly influence treatment outcomes.
    • Individualized care is crucial in managing sexual dysfunction.
    • Dosing for testosterone therapy should be carefully monitored.
    • Current medications for low libido have modest benefits.
    • Evidence for testosterone therapy in premenopausal women is still emerging.

      Tap to Follow Dr.Susan

    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    1 hr and 1 min
  • From Injections to Pills: Breaking Down the New Oral GLP-1 Data
    Oct 23 2025

    Show Notes:
    In this episode of Docs Who Lift, the Nadolsky brothers welcome back Dr. Sean Wharton, clinical trialist and one of the leading researchers behind the next generation of oral GLP-1 medications. Together, they break down:

    The OASIS-4 trial results on 25mg oral semaglutide and how it stacks up to injectable Wegovy

    How orforglipron, Eli Lilly’s new small-molecule GLP-1, differs from peptide-based drugs

    Why these new therapies could make weight management more accessible and affordable

    The fascinating pharmacology behind “snack molecules” and small-molecule receptor agonists

    Common misconceptions about bioavailability, dosing, and side effects

    The potential role of oral GLP-1s for patients with mild obesity or cardiometabolic disease

    Whether you’re a clinician, researcher, or patient curious about the future of obesity medicine, this conversation offers a clear look at how science is shifting toward needle-free solutions.

    Oasis 1 Trial Link

    Oasis 4 Trial Link

    Attain 1 Trial Link


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    32 mins
  • De-Emphasizing BMI, Prioritizing Health: What’s New in the ACE Obesity Guidelines
    Oct 13 2025

    In this episode of Docs Who Lift, the Nadolsky brothers dive deep into the newly released American Association of Clinical Endocrinology (ACE) Algorithm for Obesity Care led by Dr. Karl himself. They explore:

    Why ACE moved away from a BMI-only approach to a person-centered, complication-centric model

    The new staging framework (ABCD) that helps individualize treatment intensity

    How to interpret “clinical” vs “preclinical” obesity under the new model

    Updated targets for clinically meaningful weight loss (5%, 10%, 15% tiers)

    The emphasis on resistance training, sleep, and behavioral health alongside nutrition

    Practical guidance for selecting anti-obesity medications and identifying the right therapy for each patient

    Whether you’re a clinician, health professional, or patient trying to understand modern obesity care, this episode breaks it all down in a practical, real-world way without the jargon.

    Youtube Video to follow along the graphic mentioned


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    48 mins